FDA Inspection
Grifols Therapeutics LLCGrifols Therapeutics LLC – FDA Inspection, Sep 1, 2023
Record Details
This FDA Inspection record concerns Grifols Therapeutics LLC, with an inspection on September 1, 2023, issued by the Atlanta District Office.
- Company
- Grifols Therapeutics LLC
- Inspection Date
- September 1, 2023
- Office
- Atlanta District Office
- People
- Bradley J. Dworak
- Kula N. Jha (Issuing Officer)
- Yonggang Wang (Company Rep)
View Company Profile
ID · 8955f0eb-74f7-40f8-be3a-2ebaa64a50c8
Inspection Facts
- Inspection number
- 1221101
- FDA center
- Biologics
- Outcome
- Form 483 issued
Other FDA inspections of Grifols Therapeutics LLC
8| Date | Classification | Office | Project area |
|---|---|---|---|
| February 5, 2026 | Not classified | Atlanta District Office | Blood and Blood Products |
| May 6, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| December 13, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 10, 2017 | Not classified | Atlanta District Office | |
| October 21, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Grifols Therapeutics LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.